scholarly journals Species Distribution and In Vitro Antifungal Susceptibility Patterns of 75 Clinical Isolates of Fusarium spp. from Northern Italy

2008 ◽  
Vol 52 (7) ◽  
pp. 2683-2685 ◽  
Author(s):  
Anna Maria Tortorano ◽  
Anna Prigitano ◽  
Giovanna Dho ◽  
Maria Carmela Esposto ◽  
Claudia Gianni ◽  
...  

ABSTRACT Fusarium isolates from 75 Italian patients were identified by molecular methods, and their susceptibilities to antifungals were tested in vitro. Fusarium verticillioides was the species most frequently isolated from deep-seated infections, and F. solani was the species most frequently isolated from superficial infections. F. solani isolates showed high azole MICs, while F. verticillioides isolates showed low posaconazole MICs.

2017 ◽  
Vol 56 (4) ◽  
pp. 493-500 ◽  
Author(s):  
Fruzsina Nagy ◽  
Aliz Bozó ◽  
Zoltán Tóth ◽  
Lajos Daróczi ◽  
László Majoros ◽  
...  

2008 ◽  
Vol 52 (6) ◽  
pp. 2228-2231 ◽  
Author(s):  
Mónica Azor ◽  
Josepa Gené ◽  
Josep Cano ◽  
Deanna A. Sutton ◽  
Annette W. Fothergill ◽  
...  

ABSTRACT A microdilution method was used to test 11 antifungal drugs against clinical isolates of Fusarium thapsinum and three different phylogenetic clades of Fusarium verticillioides that were characterized by sequencing a region of the β-tubulin gene. Terbinafine was the most-active drug against both species, followed by posaconazole against F. verticillioides.


2013 ◽  
Vol 35 (1) ◽  
pp. 45-49
Author(s):  
S Mondal ◽  
A Mondal ◽  
N Pal ◽  
P Banerjee ◽  
S Kumar ◽  
...  

DOI: http://dx.doi.org/10.2126/joim.v35i1.8897 Journal of Institute of Medicine, April, 2013; 35:45-49


2008 ◽  
Vol 163 (5) ◽  
pp. 579-585 ◽  
Author(s):  
Patrícia M. Pinto ◽  
Rita de Cássia Botelho Weikert-Oliveira ◽  
Juliana Pereira Lyon ◽  
Verônica F. Cury ◽  
Rodrigo R. Arantes ◽  
...  

2021 ◽  
Vol 14 (7) ◽  
Author(s):  
Shaghayegh Rostami Yasuj ◽  
Maral Gharaghani ◽  
Seyed Sajjad Khoramrooz ◽  
Marjan Salahi ◽  
Ali Keshtkari ◽  
...  

Background: Candidemia is the most common systemic infection in hospitalized patients causing high mortality. Hence, the diagnosis of this infection in the early stage with appropriate antifungal therapy is paramount. Objectives: The study aimed at molecular identification of Candida species isolated from candidemia patients and evaluation of the in vitro antifungal susceptibility patterns of these strains to fluconazole, amphotericin B, and caspofungin. Methods: In the present study, 800 hospitalized patients who were suspected to have candidemia were sampled. Candida species were isolated and identified based on morphological characteristics and PCR-sequencing of the ITS1-5.8S-ITS2 region. Antifungal susceptibility tests for fluconazole, amphotericin B, and caspofungin were performed according to the Clinical and Laboratory Standards Institute protocol M27-A3. Also, clinical data were recorded from the patients' records. Results: Twenty-seven patients among the sample of hospitalized patients were found to have candidemia. A total of 33.3% of candidemia patients were treated with amphotericin B, in which case the mortality rate was 14.8%. The majority of patients (59%) were from the neonatal intensive care unit, and premature birth was the most common underlying condition. Candida albicans (n = 18; 66.6%) was the most common species isolated from blood cultures, followed by C. parapsilosis (n = 7; 25.9%), C. pelliculosa (n = 1; 3.7%), and C. tropicalis (n = 1; 3.7%). Only one C. albicans isolate resistant to fluconazole (minimum inhibitory concentration = 32 µg/mL). Conclusions: Generally, C. albicans has been the most frequent causative agent of candidemia. Resistance to antifungal drugs among candidemia agents was rare. Also, the identification of Candida isolates at the species level with in vitro antifungal susceptibility tests helps manage candidemia patients better and decrease the mortality rate among them.


Sign in / Sign up

Export Citation Format

Share Document